These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19555787)

  • 21. Gene-environment interaction and psychiatric disorders: Review and future directions.
    Assary E; Vincent JP; Keers R; Pluess M
    Semin Cell Dev Biol; 2018 May; 77():133-143. PubMed ID: 29051054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRF2 receptor-deficiency eliminates opiate withdrawal distress without impairing stress coping.
    Ingallinesi M; Rouibi K; Le Moine C; Papaleo F; Contarino A
    Mol Psychiatry; 2012 Dec; 17(12):1283-94. PubMed ID: 21946917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addiction as a brain disease.
    Kosten TR
    Am J Psychiatry; 1998 Jun; 155(6):711-3. PubMed ID: 9619141
    [No Abstract]   [Full Text] [Related]  

  • 24. The DSM-IV field trial for substance use disorders: major results.
    Cottler LB; Schuckit MA; Helzer JE; Crowley T; Woody G; Nathan P; Hughes J
    Drug Alcohol Depend; 1995 Apr; 38(1):59-69; discussion 71-83. PubMed ID: 7648998
    [No Abstract]   [Full Text] [Related]  

  • 25. The serotonin transporter promotor polymorphism 5-HTTLPR is not associated with alcoholism or severe forms of alcohol withdrawal in a German sample.
    Köhnke MD; Kolb W; Lutz U; Maurer S; Batra A
    Psychiatr Genet; 2006 Dec; 16(6):227-8. PubMed ID: 17106419
    [No Abstract]   [Full Text] [Related]  

  • 26. Modeling complex genetic and environmental influences on comorbid bipolar disorder with tobacco use disorder.
    McEachin RC; Saccone NL; Saccone SF; Kleyman-Smith YD; Kar T; Kare RK; Ade AS; Sartor MA; Cavalcoli JD; McInnis MG
    BMC Med Genet; 2010 Jan; 11():14. PubMed ID: 20102619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptive fitness; early life adversity improves adult stress coping in heterozygous serotonin transporter knockout rats.
    van der Doelen RH; Kozicz T; Homberg JR
    Mol Psychiatry; 2013 Dec; 18(12):1244-5. PubMed ID: 23319004
    [No Abstract]   [Full Text] [Related]  

  • 28. Addiction relapse.
    Milkman H; Weiner SE; Sunderwirth S
    Adv Alcohol Subst Abuse; 1983-1984 Fall-Winter; 3(1-2):119-34. PubMed ID: 6391101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropharmacology of addiction--setting the scene.
    Lawrence AJ; Beart PM; Kalivas PW
    Br J Pharmacol; 2008 May; 154(2):259-60. PubMed ID: 18414384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Latent class typology of nicotine withdrawal: genetic contributions and association with failed smoking cessation and psychiatric disorders.
    Xian H; Scherrer JF; Madden PA; Lyons MJ; Tsuang M; True WR; Eisen SA
    Psychol Med; 2005 Mar; 35(3):409-19. PubMed ID: 15841876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene and Environment Interactions in the Brain: A Pathway to ADHD?
    Shaw P
    Am J Psychiatry; 2015 Aug; 172(8):702-3. PubMed ID: 26234591
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of a prison smoking ban on smoking behavior and withdrawal symptoms.
    Cropsey KL; Kristeller JL
    Addict Behav; 2005 Mar; 30(3):589-94. PubMed ID: 15718077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.
    David SP; Johnstone EC; Murphy MF; Aveyard P; Guo B; Lerman C; Munafò MR
    Drug Alcohol Depend; 2008 Nov; 98(1-2):77-85. PubMed ID: 18562131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genetics, gene-environment-interactions and epigenetics in the development of depressive disorders].
    Klein AM; Glaesmer H
    Psychother Psychosom Med Psychol; 2012; 62(3-4):95-101. PubMed ID: 22473427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Special issue on neuropeptides in stress and addiction: Overview.
    Valentino R; Aston-Jones G
    Brain Res; 2010 Feb; 1314():1-2. PubMed ID: 20141765
    [No Abstract]   [Full Text] [Related]  

  • 36. Addiction to an experience: a social-psychological-pharmacological theory of addiction.
    Peele S
    NIDA Res Monogr; 1980 Mar; 30():142-6. PubMed ID: 6779171
    [No Abstract]   [Full Text] [Related]  

  • 37. Tolerance and Effectiveness of Forced and Prolonged Smoking Cessation Among French Submariners.
    Derkenne C; Bylicki O; Darléguy A; Garnier M; Baert P; Lamblin A
    Mil Med; 2016 May; 181(5):445-50. PubMed ID: 27136651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tobacco "chippers"--individual differences in tobacco dependence.
    Shiffman S
    Psychopharmacology (Berl); 1989; 97(4):539-47. PubMed ID: 2498951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug dependence: stress and dysregulation of brain reward pathways.
    Kreek MJ; Koob GF
    Drug Alcohol Depend; 1998; 51(1-2):23-47. PubMed ID: 9716928
    [No Abstract]   [Full Text] [Related]  

  • 40. Association study of trauma load and SLC6A4 promoter polymorphism in posttraumatic stress disorder: evidence from survivors of the Rwandan genocide.
    Kolassa IT; Ertl V; Eckart C; Glöckner F; Kolassa S; Papassotiropoulos A; de Quervain DJ; Elbert T
    J Clin Psychiatry; 2010 May; 71(5):543-7. PubMed ID: 20441718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.